Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee

Int J Gynecol Cancer. 2022 Jul 12;32(10):1316-1320. doi: 10.1136/ijgc-2022-003685. Online ahead of print.

Nadja Taumberger¹, Elmar A Joura², Marc Arbyn^{3

4}, Maria Kyrgiou^{5

6}, Jalid Sehouli⁷, Murat Gultekin^{4

8}

¹ Department of Obstetrics and Gynaecology, Medical University of Graz, Graz, Austria.
² Department of Obstetrics and Gynaecology, Division of Gynecologic Oncology, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria elmar.joura@meduniwien.ac.at.
³ Unit of Cancer Epidemiology, Belgian Cancer Centre Sciensano, Brussels, Belgium.
⁴ Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium.
⁵ Department of Metabolism, Digestion and Reproduction - Surgery and Cancer, Institute of Reproductive and Developmental Biology, Imperial College London, London, UK.
⁶ Imperial College Healthcare NHS Trust, London, UK.
⁷ Department of Gynaecology and Obstetrics with Centre of Oncological Surgery, Charité Universitatsmedizin Berlin, Charité, Berlin, Germany.
⁸ Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

No abstract available

Keywords: Cervical Cancer; Gynecology; Pathology.

Publication types